ACR 2021

November 1–10, 2021, Virtual

Amgen is proud to be part of the American College of Rheumatology Convergence for 2021 (ACR 2021). While you’re here, you can explore the latest scientific information and disease state education. Additionally, you can learn about Amgen’s long-term commitment to developing and delivering transformative medicines for patients with inflammatory diseases.

Amgen | A Worldwide Pioneer in Biotechnology

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit and follow us on